secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2024-12-31T23:59:59+00:00
Accession:  0001437749-24-038599
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart receives second 180-day Nasdaq extension to cure bid price deficiency until June 30, 2025
--------------------------------------------------------------------------------

- Nasdaq notified Vaxart on Dec 31, 2024 of an additional 180-day compliance period to meet the $1.00 minimum bid price requirement.
- Extension moves the cure deadline from Dec 30, 2024 to June 30, 2025.
- Company is considering a reverse stock split as a potential cure for the deficiency.
- If not compliant by June 30, 2025, Nasdaq will issue a delisting notice; Vaxart may appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774924038599/0001437749-24-038599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774924038599/vxrt20241231_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-038599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer